Angiogenic profile of uveal melanoma

Current Eye Research

Volumn 31, Issue 9, 2006, Pages 775-785

  Notting, Irene Christa ^a   Missotten, Guy Sam Omer Antoon ^a   Sijmons, Bianca ^a   Boonman, Zita Francisca Helena Maria ^a   Keunen, Jan Ernest Everard ^b   Van Der Pluijm, Gabriel ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; In patients; In vitro; In vivo; Uveal melanoma

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTERIOR EYE SEGMENT; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOCYTES; MELANOMA; MICE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 33748565945     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680600865052     Document Type: Article

References (40)

1. Egan K, Seddon J, Glynn R, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239-251.
2. Pyrhonen S. The treatment of metastastic uveal melanoma. Eur J Cancer. 1998;34(Suppl):s27-30.
3. Clark A, Mellon J, Li X, et al. Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci. 1999;40:2158-2162.
4. Shih I, Herlyn M. Role of growth factors and their receptors in the development and progression of melanoma. J Invest Dermatol. 1993;100:196S-203S.
5. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev. 1993;12:219-226.
6. Relf M, LeJeune S, Scott P, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 1997;57:963-969.
7. Shibusa T, Shijubo N, Abe S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res. 1998;4:1483-1487.
8. Kumar H, Heer K, Lee P, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res. 1998;4:1279-1285.
9. Salven P, Lymboussaki A, Heikkila P, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol. 1998;153:103-108.
10. Boyd S, Tan D, Bunce C, et al. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol. 2002;86:448-452.
11. Missotten G, Boyd S, Keunen J, Jager M. Prognostic value of VEGF-A in aqueous humour of uveal melanoma patients. Ophthalmic Res. 2002;34:143.
12. Boyd S, Tan D, de Souza L, et al. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol. 2002;86:440-447.
13. Sheidow T, Hooper P, Crukley C, et al. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophthalmol. 2000;84:750-756.
14. Clarijs R, Schalwijk L, Ruiter D, de Waal R. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptors Flt-4 in uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:1422-1428.
15. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995;92:3566-3570.
16. Achen M, Williams R, Minekus M, et al. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumor angiogenesis. J Pathol. 2001;193:147-154.
17. Reed J, Albino A. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Clin Lab Med. 2000;20:817-838.
18. Graeven U, Rodeck U, Karpinski S, et al. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibrobast growth factor. Cancer Res. 2001;61:7282-7290.
19. Chen P, Murray T, Uno T, et al. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis. 1997;15:509-518.
20. Kan-Mitchell J, Mitchell M, Rao N, Liggett P. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci. 1989;30:829-834.
21. Luyten G, Naus N, Mooy C, et al. Establishment and characterization of primary and metatstatic uveal melanoma cell line. Int J Cancer. 1996;66:380-387.
22. De Waard-Siebinga I, Blom D, Griffioen M, et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer. 1995;62:155-161.
23. Hu D, Mc Cormick S, Ritch R, Pelton-Herion K. Studies of uveal melanoma melanocytes in vitro: Isolation, purifivation and cultivation of uveal melanocytes. Invest Ophthalmol Vis Sci. 1993;34:2210-2219.
24. Niederkorn J, Steilein J, Shadduck J. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice. Invest Ophthalmol Vis Sci. 1981;20:355-363.
25. Apte R, Niederkorn J, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastasis. Arch Ophthal. 2001;119:1805-1818.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
27. Van der Pluijm G, Sijmons B, Vloedgraven H, et al. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastasis. J Bone Miner Res. 2001;16:1077-1091.
28. Deckers M, van der Pluijm G, Dooijewaard S, et al. Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants. Lab Invest. 2001;81:5-15.
29. Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nat Rev Cancer. 2002;2:795-803.
30. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 2002;82:673-700.
31. Kvanta A, Steen B, Seregard S. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma. Exp Eye Res. 1996;63:511-518.
32. Stitt A, Simpson D, Boocock C, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumors. J Pathol. 1998;186:306-312.
33. Li X, Eriksson U. Novel VEGF family members: VEGF-B, VEGF-C, and VEGF-D. Int J Biochem Cell Biol. 2001;33:421-426.
34. Enholm B, Paavonen K, Ristimaki A, et al. Comparison of VEGF, VEGF-B, VEGF-C, and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14:2475-2483.
35. Seftor E, Meltzer P, Schatteman G, et al. Expression of multiple molecular phemotypes by aggressive melanoma tumor cells: Role in vasculogenic mimicry. Crit Rev Oncol Hematol. 2002;44:17-27.
36. Woll E, Bedikian A, Legha S. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res. 1999;9:575-581.
37. Dithmer S, Diaz C, Grossniklaus H. Intraocular melanoma spread to regional lymph nodes: report of two cases. Retina 2000;20:76-79.
38. Pepper MS. Lymphangiogenesis and tumor metastasis: Myth or reality? Clin Cancer Res. 2001;7:462-468.
39. Ijland S, Jager M, Heijdra B, et al. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines. Melanoma Res. 1999;9:445-450.
40. Wang Y, Becker D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med. 1997;3:887-893.